Cargando…
Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies
Aim: To evaluate the effect of the initial dose of poractant alfa on clinical outcomes in neonatal respiratory distress syndrome (RDS) and to assess adherence to treatment guidelines recommending a dose of 200 mg/kg. Methods: Records of neonates who received poractant alfa with a less invasive techn...
Autores principales: | Królak-Olejnik, Barbara, Hożejowski, Roman, Szczapa, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732442/ https://www.ncbi.nlm.nih.gov/pubmed/33330292 http://dx.doi.org/10.3389/fped.2020.603716 |
Ejemplares similares
-
FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021) -
In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome
por: Ricci, Francesca, et al.
Publicado: (2017) -
Poractant alfa (Curosurf(®)) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
por: Willems, Coen HMP, et al.
Publicado: (2012) -
The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
por: Pezzi, Mario, et al.
Publicado: (2020) -
Safety and efficacy of a novel double-lumen tracheal tube in neonates with RDS: A prospective cohort study
por: Li, Chuanfeng, et al.
Publicado: (2022)